Mabwell (Shanghai) Bioscience Co., Ltd. (SHA:688062)
China · Delayed Price · Currency is CNY 22.91
+1.12 (5.14%)
Oct 23, 2026, 2:45 PM CST
SHA:688062 Market Cap
SHA:688062 has a market cap or net worth of 9.93 billion as of October 22, 2026. It is the 8,303rd most valuable company in the world and the 1,653rd biggest in China. Its market cap has decreased by 44.34% in one year.
Market Cap
9.93B
Enterprise Value
11.11B
Revenue
873.99M
Global Rank
Country Rank
#1,653 China
PE Ratio
n/a
ChartMarket Cap Chart
Since January 18, 2022, SHA:688062's market cap has increased from 9.79B to 9.93B, an increase of 1.45%. That is a compound annual growth rate of 0.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 9.93B | -35.36% |
| Dec 31, 2025 | 15.36B | 90.35% |
| Dec 31, 2024 | 8.07B | -38.21% |
| Dec 29, 2023 | 13.06B | 126.23% |
| Dec 30, 2022 | 5.77B | -41.02% |
| Jan 18, 2022 | 9.79B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tibet Cheezheng Tibetan Medicine | 10.90B |
| Chengdu Olymvax Biopharmaceuticals | 10.82B |
| Shanghai Medicilon | 10.76B |
| Inner Mongolia Furui Medical Science | 10.58B |
| Chengzhi | 9.87B |
| Staidson (Beijing) BioPharmaceuticals | 9.86B |
| Novoprotein Scientific | 9.28B |
| Pacific Shuanglin Bio-pharmacy | 9.15B |